Literature DB >> 19522658

Serogroup-specific risk factors for Shiga toxin-producing Escherichia coli infection in Australia.

Michelle McPherson1, Karin Lalor, Barry Combs, Jane Raupach, Russell Stafford, Martyn D Kirk.   

Abstract

BACKGROUND: Shiga toxin-producing Escherichia coli (STEC) is an important cause of foodborne illness. In Australia, risk factors for STEC infection have not been examined at a national level.
METHODS: We conducted a case-control study in 6 Australian jurisdictions from 2003 through 2007. A case patient was defined as a person from whom STEC was isolated or toxin production genes were detected in stool. Case patients were recruited from notifiable disease registers, and 3 control subjects frequency matched by age were selected from databases of controls. Using structured questionnaires, interviewers collected data on clinical illness, foods consumed, and exposures to potential environmental sources.
RESULTS: We recruited 43 case patients infected with STEC serogroup O157, 71 case patients infected with non-O157 serogroups, and 304 control subjects. One patient infected with serogroup O157 and 7 infected with non-O157 serogroups developed hemolytic uremic syndrome. Compared with control subjects, case patients infected with STEC O157 were more likely to eat hamburgers, visit restaurants, have previously used antibiotics, or have family occupational exposure to red meat. Case patients infected with non-O157 STEC were more likely to eat sliced chicken meat or corned beef from a delicatessen, camp in the bush, eat catered meals, or have family occupational exposure to animals. Negative associations were observed for certain foods, particularly homegrown vegetables, fruits, or herbs.
CONCLUSION: This study of risk factors for STEC infection by serogroup highlights risks associated with eating hamburgers and occupational handling of raw meat. To prevent infection, hamburgers must be cooked thoroughly, and people handling raw meat or who have close contact with animals must ensure adequate hygiene.

Entities:  

Mesh:

Year:  2009        PMID: 19522658     DOI: 10.1086/599370

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

Review 1.  Case-control studies of sporadic enteric infections: a review and discussion of studies conducted internationally from 1990 to 2009.

Authors:  Kathleen E Fullerton; Elaine Scallan; Martyn D Kirk; Barbara E Mahon; Frederick J Angulo; Henriette de Valk; Wilfrid van Pelt; Charmaine Gauci; Anja M Hauri; Shannon Majowicz; Sarah J O'Brien
Journal:  Foodborne Pathog Dis       Date:  2012-04       Impact factor: 3.171

2.  Molecular Prediction of the O157:H-Negative Phenotype Prevalent in Australian Shiga Toxin-Producing Escherichia coli Cases Improves Concordance of In Silico Serotyping with Phenotypic Motility.

Authors:  Alexander P Pintara; Christine J D Guglielmino; Irani U Rathnayake; Flavia Huygens; Amy V Jennison
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

3.  Comparison of clinical and epidemiological features of Shiga toxin-producing Escherichia coli O157 and non-O157 infections in British Columbia, 2009 to 2011.

Authors:  Xuetao Wang; Marsha Taylor; Linda Hoang; Judi Ekkert; Craig Nowakowski; Jason Stone; Greg Tone; Steven Trerise; Ana Paccagnella; Titus Wong; Eleni Galanis
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  Phylogenetically related Argentinean and Australian Escherichia coli O157 isolates are distinguished by virulence clades and alternative Shiga toxin 1 and 2 prophages.

Authors:  Glen E Mellor; Eby M Sim; Robert S Barlow; Beatriz A D'Astek; Lucia Galli; Isabel Chinen; Marta Rivas; Kari S Gobius
Journal:  Appl Environ Microbiol       Date:  2012-04-27       Impact factor: 4.792

5.  Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010.

Authors:  Hassan Vally; Gillian Hall; Amalie Dyda; Jane Raupach; Katrina Knope; Barry Combs; Patricia Desmarchelier
Journal:  BMC Public Health       Date:  2012-01-21       Impact factor: 3.295

6.  A prospective case-control and molecular epidemiological study of human cases of Shiga toxin-producing Escherichia coli in New Zealand.

Authors:  Patricia Jaros; Adrian L Cookson; Donald M Campbell; Thomas E Besser; Smriti Shringi; Graham F Mackereth; Esther Lim; Liza Lopez; Muriel Dufour; Jonathan C Marshall; Michael G Baker; Steve Hathaway; Deborah J Prattley; Nigel P French
Journal:  BMC Infect Dis       Date:  2013-09-30       Impact factor: 3.090

7.  Food safety: pathogen transmission routes, hygiene practices and prevention.

Authors:  Leanne E Unicomb
Journal:  J Health Popul Nutr       Date:  2009-10       Impact factor: 2.000

Review 8.  Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease.

Authors:  Christa L Fischer Walker; Jennifer A Applegate; Robert E Black
Journal:  J Health Popul Nutr       Date:  2012-09       Impact factor: 2.000

9.  Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 and non-O157 illness in The Netherlands, 2008-2012, using periodically surveyed controls.

Authors:  I H M Friesema; M Schotsborg; M E O C Heck; W Van Pelt
Journal:  Epidemiol Infect       Date:  2014-09-08       Impact factor: 4.434

10.  Shiga toxin-producing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups--except O104.

Authors:  Karina Preußel; Michael Höhle; Klaus Stark; Dirk Werber
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.